USP9XPEG10T

Shan Xiong1, Fengjie Liu1, Jingru Sun1

  • 1Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.

概括

研究人员确定USP9X是稳定PEG10的关键调节剂,这是激进皮肤T细胞淋巴瘤 (CTCL) 的驱动因素. 抑制USP9X通过降低PEG10的调节和阻碍瘤生长,显示出治疗晚期CTCL的前景.